{
    "name": "talimogene laherparepvec",
    "comment": "Rx",
    "other_names": [
        "Imlygic"
    ],
    "classes": [
        "Oncolytic Immunotherapy"
    ],
    "source": "https://reference.medscape.com/drug/imlygic-talimogene-laherparepvec-1000001",
    "pregnancy": {
        "common": [
            "Contraindicated in pregnancy because of the risk of transmitting wild-type HSV-1 cross the placental barrier and the risk of transmission during birth owing to viral shedding",
            "Female patients of childbearing potential should use an effective method of contraception to prevent pregnancy during treatment",
            "Infections with wild-type HSV-1 have been associated with serious adverse effects, including multiorgan failure and death, if a fetus or neonate contracts the wild-type herpes infection",
            "No effects on embryo-fetal development have been observed in a study conducted in pregnant mice; the design of the study limits application of the animal data to humans"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Unknown if distributed in human breast milk; because medicinal products can be found in human milk, a decision should be made whether to discontinue nursing or to discontinue the drug while nursing"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Immunocompromised patients; talimogene laherparepvec is a live, attenuated herpes simplex virus and may cause life-threatening disseminated herpetic infection in patients who are immunocompromised; do not administer to immunocompromised patients, including those with a history of primary or acquired immunodeficient states, leukemia, lymphoma, AIDS or other clinical manifestations of infection with human immunodeficiency viruses, and those on immunosuppressive therapy",
                "Pregnant women"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Accidental exposure may lead to transmission of herpetic infection; accidental needle stick and splash-back to the eyes have been reported in healthcare providers during preparation and administration; use universal chemotherapy handling precautions",
                "Healthcare providers, close contacts (household members, caregivers, sex partners, or persons sharing the same bed), pregnant women, and newborns should avoid direct contact with injected lesions, dressings, or body fluids of treated patients",
                "Healthcare providers who are immunocompromised or pregnant should not prepare or administer talimogene laherparepvec (see Contraindications)",
                "Herpetic infections, including cold sores and herpetic keratitis, reported in treated patients; disseminated herpetic infection may also occur in immunocompromised patients (see Contraindications)",
                "Injection site complications, including necrosis or ulceration of tumor tissue, may occur during treatment; cellulitis and systemic bacterial infection have been reported; careful wound care and infection precautions are recommended, particularly if tissue necrosis results in open wounds; consider the risks and benefits before continuing treatment",
                "Treatment may result in immune-mediated events, including glomerulonephritis, vasculitis, pneumonitis, worsening psoriasis, and vitiligo; consider the risks and benefits before initiating treatment",
                "Plasmacytoma has been reported in proximity to the injection site after administration in a patient with smoldering multiple myeloma; consider risks and benefits in patients with multiple myeloma or in whom plasmacytoma develops during treatmen"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Contraindicated",
            "interaction_with": "ifosfamide",
            "description": {
                "common": "ifosfamide, talimogene laherparepvec.\nEither increases effects of the other by immunosuppressive effects; risk of infection. Contraindicated. Patients on concomitant immunosuppressants or with impaired immune systems are contraindicated to receive talimogene laherparepvec because of increased risk for serious infections."
            }
        },
        {
            "classification_type": "Contraindicated",
            "interaction_with": "ublituximab",
            "description": {
                "common": "ublituximab and talimogene laherparepvec both increase  immunosuppressive effects; risk of infection. Contraindicated. Talimogene laherparepvec is a live, attenuated herpes simplex virus and may cause life-threatening disseminated herpetic infection in patients who are immunocompromised"
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "acyclovir",
            "description": {
                "common": "acyclovir decreases effects of talimogene laherparepvec by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Although no drug interactions studies have been performed, antiherpetic viral agents may interfere with the effectiveness of talimogene laherparepvec."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "acyclovir topical",
            "description": {
                "common": "acyclovir topical decreases effects of talimogene laherparepvec by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Although no drug interactions studies have been performed, antiherpetic viral agents may interfere with the effectiveness of talimogene laherparepvec."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "famciclovir",
            "description": {
                "common": "famciclovir decreases effects of talimogene laherparepvec by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Although no drug interactions studies have been performed, antiherpetic viral agents may interfere with the effectiveness of talimogene laherparepvec."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "ganciclovir",
            "description": {
                "common": "ganciclovir decreases effects of talimogene laherparepvec by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Although no drug interactions studies have been performed, antiherpetic viral agents may interfere with the effectiveness of talimogene laherparepvec."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "penciclovir",
            "description": {
                "common": "penciclovir decreases effects of talimogene laherparepvec by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Although no drug interactions studies have been performed, antiherpetic viral agents may interfere with the effectiveness of talimogene laherparepvec."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "valacyclovir",
            "description": {
                "common": "valacyclovir decreases effects of talimogene laherparepvec by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Although no drug interactions studies have been performed, antiherpetic viral agents may interfere with the effectiveness of talimogene laherparepvec."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "valganciclovir",
            "description": {
                "common": "valganciclovir decreases effects of talimogene laherparepvec by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Although no drug interactions studies have been performed, antiherpetic viral agents may interfere with the effectiveness of talimogene laherparepvec."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Fatigue",
            "percent": "50.3"
        },
        {
            "name": "all grades",
            "percent": "48.6"
        },
        {
            "name": "Chills",
            "percent": "42.8"
        },
        {
            "name": "all grades",
            "percent": "35.6"
        },
        {
            "name": "Pyrexia",
            "percent": "30.5"
        },
        {
            "name": "all grades",
            "percent": "27.7"
        },
        {
            "name": "Nausea",
            "percent": "21.2"
        },
        {
            "name": "all grades",
            "percent": "18.8"
        },
        {
            "name": "Influenzalike illness",
            "percent": "18.8"
        },
        {
            "name": "all grades",
            "percent": "17.5"
        },
        {
            "name": "Injection site pain",
            "percent": "17.1"
        },
        {
            "name": "all grades",
            "percent": "16.4"
        },
        {
            "name": "Vomiting",
            "percent": "11.6"
        },
        {
            "name": "all grades",
            "percent": "9.6"
        },
        {
            "name": "Diarrhea",
            "percent": "8.9"
        },
        {
            "name": "all grades",
            "percent": "5.8"
        },
        {
            "name": "Headache",
            "percent": "5.8"
        },
        {
            "name": "all grades",
            "percent": "3"
        },
        {
            "name": "Myalgia",
            "percent": "2.1"
        },
        {
            "name": "all grades",
            "percent": "3"
        },
        {
            "name": "Arthralgia",
            "percent": "1.7"
        },
        {
            "name": "all grades",
            "percent": "3"
        },
        {
            "name": "Pain in extremity",
            "percent": "1.4"
        },
        {
            "name": "all grades",
            "percent": "3"
        },
        {
            "name": "Constipation",
            "percent": "3"
        },
        {
            "name": "all grades",
            "percent": "3"
        },
        {
            "name": "Dizziness",
            "percent": "3"
        },
        {
            "name": "all grades",
            "percent": "3"
        },
        {
            "name": "Abdominal pain",
            "percent": "3"
        },
        {
            "name": "all grades",
            "percent": "3"
        },
        {
            "name": "Oropharyngeal pain",
            "percent": "3"
        },
        {
            "name": "all grades",
            "percent": "3"
        },
        {
            "name": "Weight decreased",
            "percent": null
        },
        {
            "name": "all grades",
            "percent": null
        },
        {
            "name": "Fatigue",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Vomiting",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Pain in extremity",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Influenzalike illness",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Injection site pain",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Myalgia",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Arthralgia",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "Weight decreased",
            "percent": null
        },
        {
            "name": "grade",
            "percent": null
        }
    ]
}